# Regenicin, Inc. (RGIN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RGIN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 0 | $ -363.8K | $ -355.0K | $ 642.9K | $ -6.21M |
| 2022 | $ 0 | $ -894.4K | $ -422.8K | $ 642.9K | $ -5.87M |
| 2021 | $ 0 | $ -790.1K | $ -27.5K | $ 613.4K | $ -5.11M |
| 2020 | $ 0 | $ -664.8K | $ -68.3K | $ 589.5K | $ -4.45M |
| 2019 | $ 0 | $ -915.3K | $ -136.9K | $ 536.8K | $ -3.93M |
| 2018 | $ 0 | $ -789.2K | $ -250.3K | $ 460.7K | $ -3.22M |
| 2017 | $ 0 | $ -1.21M | $ -272.1K | $ 276.6K | $ -2.62M |
| 2016 | $ 0 | $ -1.39M | $ -801.0K | $ 185.0K | $ -1.75M |
| 2015 | $ 0 | $ -3.56M | $ -2.86M | $ 175.0K | $ -1.22M |
| 2014 | $ 0 | $ 6.50M | $ -528.5K | $ 634.4K | $ 723.5K |
| 2013 | $ 0 | $ -6.25M | $ -868.0K | $ 818.0K | $ -3.90M |
| 2012 | $ 18.2K | $ -4.21M | $ -1.50M | $ 511.8K | $ -469.8K |
| 2011 | $ 0 | $ -5.45M | $ -2.10M | $ 186.5K | $ 831.6K |
| 2010 | $ -39.3K | $ -2.58M | $ -1.28M | $ 150.0K | $ 2.45M |
| 2009 | $ 0 | $ -16.7K | $ -26.5K | $ 0 | $ -18.5K |
| 2008 | $ 0 | $ -14.4K | $ 53.0K | $ 0 | $ -7.5K |
| 2007 | $ 0 | $ -56.0K | $ -53.0K | $ 0 | $ 2.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.10 |
| Liabilities / Eq | -2.91 |
| Current Ratio | 0.66 |

## Other views

- [Metrics](https://sponda.capital/en/RGIN.md)
- [Charts](https://sponda.capital/en/RGIN/charts.md)
- [Compare](https://sponda.capital/en/RGIN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.